NLSP and NLSPW Related Headlines

Go Back

Oct 30, 2025 04:16PM NLS Pharmaceutics and Kadimastem complete merger as NewcelX
Oct 30, 2025 04:15PM NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Oct 30, 2025 07:01AM NLS Pharmaceutics adds AEX-6xx compounds to CNS drug pipeline
Oct 30, 2025 07:00AM NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
Oct 29, 2025 06:00AM NLS Pharmaceutics announces reverse stock split ahead of Kadimastem merger
Oct 29, 2025 06:00AM NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
Oct 29, 2025 03:53AM NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 27, 2025 07:00AM Kadimastem partners with TargetGene for gene-edited cell therapies
Oct 27, 2025 07:00AM NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies
Oct 23, 2025 06:03AM NLS Pharmaceutics and Kadimastem receive Nasdaq approval for merger
Oct 23, 2025 06:01AM NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
Sep 30, 2025 07:01AM NLS Pharmaceutics shareholders approve merger with Kadimastem
Sep 30, 2025 07:00AM NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
Sep 10, 2025 06:00AM Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger

NLSP and NLSPW Related Press Releases

Go Back

Oct 30, 2025 04:15PM NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
Oct 30, 2025 07:00AM NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs
Oct 29, 2025 06:00AM NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
Oct 29, 2025 03:53AM NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 27, 2025 07:00AM NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies
Oct 23, 2025 06:01AM NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025
Sep 30, 2025 07:00AM NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
Sep 10, 2025 06:00AM Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger

NLSP and NLSPW Related SEC Filings

Go Back